The Biden administration’s pandemic agenda must not ignore superbugs

  04 March 2021

What if another devastating pandemic came on the heels of Covid-19?

Unfortunately, that looks increasingly possible. For years, the antibiotics used to fight various bacterial infections have grown gradually less effective. If current trends continue, these antibiotics could stop working altogether in the near future, leaving humanity vulnerable to deadly, drug-resistant “superbugs.”

Preventing this public health threat will require an aggressive, federally backed effort to develop new and more potent antibiotics. As the Biden administration begins thinking about pandemic preparedness, it should focus on jump-starting innovation in developing new antimicrobial drugs.

Further reading: Stat News
Author(s): Michelle McMurry-Heath
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!